MedTrace Logo

Use of Continuous Glucose Monitors in Children and Adolescents With Obesity

NCT06254768 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-02-12

No results posted yet for this study

Summary

To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.

Conditions

  • Pediatric Obesity

Interventions

DEVICE

Continuous glucose monitor

its a device used to measure glucose from interstitial fluids and provides feedback regarding the same every 5 minutes.

Sponsors & Collaborators

Principal Investigators

  • Steven D Mittelman, MD, PhD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
10 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-17
Primary Completion
2024-03-31
Completion
2024-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06254768 on ClinicalTrials.gov